These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19969443)

  • 1. Estimation of an optimal utilisation rate for palliative radiotherapy in newly diagnosed cancer patients.
    Jacob S; Wong K; Delaney GP; Adams P; Barton MB
    Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):56-64. PubMed ID: 19969443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of an optimal chemotherapy utilisation rate for colon cancer: an evidence-based benchmark for cancer care.
    Jacob S; Ng W; Asghari R; Delaney GP; Barton MB
    Eur J Cancer; 2009 Sep; 45(14):2503-9. PubMed ID: 19527926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the optimal radiotherapy utilization for carcinoma of the central nervous system, thyroid carcinoma, and carcinoma of unknown primary origin from evidence-based clinical guidelines.
    Delaney G; Jacob S; Barton M
    Cancer; 2006 Jan; 106(2):453-65. PubMed ID: 16355366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines.
    Delaney G; Jacob S; Featherstone C; Barton M
    Cancer; 2005 Sep; 104(6):1129-37. PubMed ID: 16080176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma: a review of the evidence.
    Delaney G; Barton M; Jacob S
    Cancer; 2004 Aug; 101(4):657-70. PubMed ID: 15305395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part II--carcinoma of the endometrium.
    Delaney G; Jacob S; Barton M
    Cancer; 2004 Aug; 101(4):682-92. PubMed ID: 15305397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part I--malignancies of the cervix, ovary, vagina and vulva.
    Delaney G; Jacob S; Barton M
    Cancer; 2004 Aug; 101(4):671-81. PubMed ID: 15305396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of an optimal radiotherapy utilization rate for melanoma: a review of the evidence.
    Delaney G; Barton M; Jacob S
    Cancer; 2004 Mar; 100(6):1293-301. PubMed ID: 15022299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy in England in 2007: modelled demand and audited activity.
    Williams MV; Drinkwater KJ
    Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):575-90. PubMed ID: 19651499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective survey of radiotherapy in Sweden.
    Acta Oncol; 1996; 35 Suppl 6():47-56. PubMed ID: 9154085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma.
    Delaney G; Jacob S; Barton M
    Cancer; 2005 Jun; 103(11):2216-27. PubMed ID: 15856428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of an optimal chemotherapy utilisation rate for head and neck carcinoma: setting an evidence-based benchmark for the best-quality cancer care.
    Ng W; Jacob S; Delaney G; Barton M
    Eur J Cancer; 2009 Aug; 45(12):2150-9. PubMed ID: 19285857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of an optimal chemotherapy utilisation rate for breast cancer: setting an evidence-based benchmark for the best-quality cancer care.
    Ng W; Delaney GP; Jacob S; Barton MB
    Eur J Cancer; 2010 Mar; 46(4):703-12. PubMed ID: 20034784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence: part II-leukemia and myeloma.
    Featherstone C; Delaney G; Jacob S; Barton M
    Cancer; 2005 Jan; 103(2):393-401. PubMed ID: 15593373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Underutilization of radiotherapy for lung cancer in New South Wales, Australia.
    Vinod SK; Simonella L; Goldsbury D; Delaney GP; Armstrong B; O'Connell DL
    Cancer; 2010 Feb; 116(3):686-94. PubMed ID: 19957325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence: part I-lymphoma.
    Featherstone C; Delaney G; Jacob S; Barton M
    Cancer; 2005 Jan; 103(2):383-92. PubMed ID: 15599937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of an optimal radiotherapy utilization rate for breast carcinoma: a review of the evidence.
    Delaney G; Barton M; Jacob S
    Cancer; 2003 Nov; 98(9):1977-86. PubMed ID: 14584082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing treatment benchmarks for mammography-screened breast cancer population based on a review of evidence-based clinical guidelines.
    Delaney G; Shafiq J; Chappell G; Barton M
    Cancer; 2008 May; 112(9):1912-22. PubMed ID: 18318431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the optimal external-beam radiotherapy utilization rate for genitourinary malignancies.
    Delaney G; Jacob S; Barton M
    Cancer; 2005 Feb; 103(3):462-73. PubMed ID: 15612081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.